Short interest for SI-BONE gives investors a sense of the degree to which investors are betting on the decline of SI-BONE's stock. Short interest data is updated every two weeks.

SI-BONE Stock (NASDAQ:SIBN), Short Interest Report

SI-BONE

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

Analyst Color

Equities

News

Price Target

Reiteration

Small Cap

Markets

Analyst Ratings

Trading Ideas

General

SIBN

Needham analyst David Saxon reiterated a Buy rating on SI-BONE, Inc (NASDAQ: SIBN), 

SI-BONE Poised For A Surge: Analyst Highlights Upside Potential With New Product Launches

Earnings

Penny Stocks

Eurozone

Commodities

Global

Intraday Update

CHGG

CIGI

IMTX

UBER

VSEC

U.S. stocks traded lower this morning even as the Federal Reserve’s two-day meeting began.

Following the market opening Tuesday, the Dow traded down 0.47% to 33,891.31 while the NASDAQ fell 0.12% to 12,197.84. The S&amp;P 500 also declined, losing 0.37% to 4,152.34.

US Stocks Down; Chegg Crashes After Removing Guidance On ChatGPT Concerns

Guidance

Health Care

Movers

Analysts Remain Bullish On SI-BONE, Forecast Q4&#39;s Strength To Continue In 2023

SI-BONE Inc

Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down

Truist Financial analyst Samuel Brodovsky maintained a Buy rating on SI-Bone (SIBN – Research Report) yesterday and set a price target of $20.00. T...

Truist Financial Sticks to Their Buy Rating for SI-Bone (SIBN)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on SI-Bone (SIBN – Research Report), Conmed (CNMD – Research Report)...

Analysts' Opinions Are Mixed on These Healthcare Stocks: SI-Bone (SIBN), Conmed (CNMD) and Chemed (CHE)

SI-BONE GAAP EPS of -$0.27 beats by $0.05, revenue of $37.9M beats by $1.41M

SI-BONE, Inc. (SIBN) Q1 2024 Earnings Call Transcript

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>SI-BONE</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/sibn-stock-quote/"><strong>SIBN</strong></a></span>) just reported results for the first quarter of 2024.</p><ul><li>SI-BONE reported earnings per share of -27 cents. This was above the analyst estimate for EPS of -31 cents.</li><li>The company reported revenue of $37.87 million.</li><li>This was 3.77% better than the analyst estimate for revenue of $36.49 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/05/sibn-stock-earnings-si-bone-for-q1-of-2024/">SIBN Stock Earnings: SI-BONE Beats EPS, Beats Revenue for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

SIBN Stock Earnings: SI-BONE Beats EPS, Beats Revenue for Q1 2024

In a report released today, David Turkaly from JMP Securities reiterated a Buy rating on SI-Bone (SIBN – Research Report), with a price target of $...

JMP Securities Reaffirms Their Buy Rating on SI-Bone (SIBN)

Bank of America Securities analyst Craig Bijou reiterated a Buy rating on SI-Bone (SIBN – Research Report) today and set a price target of $21.00. ...

SI-Bone's Strong Start and Revenue Growth Potential Affirm Buy Rating

Canaccord Genuity analyst Caitlin Cronin has maintained their bullish stance on SIBN stock, giving a Buy rating today. Caitlin Cronin's rating is b...

Positive Outlook for SI-Bone: Robust Revenue Growth and Strategic Advances Reinforce Buy Rating

In a report released today, Samuel Brodovsky from Truist Financial reiterated a Buy rating on SI-Bone (SIBN – Research Report). The company's share...

Truist Financial Sticks to Its Buy Rating for SI-Bone (SIBN)

AORT

ATEC

ATRC

AZTA

CNMD

ENOV

GKOS

IRTC

ISRG

KIDS

LIVN

NARI

RXST

SRDX

VCYT

XRAY

Press Releases

SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023

SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application

SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024

SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance

SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024

SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024

SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024

SI-BONE, Inc. Reports Financial Results for the First Quarter 2024

SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures

-

-

-

-

-

-

-

-

-

-

-

-

-

-

SI-BONE Stock (NASDAQ:SIBN), Short Interest Report

People Also Watch